How many insider declarations has Schultes Birgit C filed?

Schultes Birgit C has filed 4 public insider declarations with SEC (Form 4).

What is Schultes Birgit C's role?

Schultes Birgit C's reported role is not specified by the regulator across the filings.

Which companies does Schultes Birgit C report trades for?

Schultes Birgit C reports trades for Intellia Therapeutics, Inc..

What is Schultes Birgit C's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 67k€.

← Executives ★ Sign in to follow

SB

Schultes Birgit C

OFFICER

·SEC (Form 4)

Intellia Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€67,406

▼ Sales (2 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

2

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the detailed record of transactions filed by Schultes Birgit C. Insider active across 1 company, notably Intellia Therapeutics, Inc.. In total, 4 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €67k. History available since 1 March 2025. The latest transaction was filed on 1 March 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to Schultes Birgit C

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Intellia Therapeutics, Inc. (US)

Declarations4 total

◆

Schultes Birgit C

EVP, Chief Scientific OfficerExecutives1 Mar 2026Intellia Therapeutics, Inc.

0SEC ↗

39,200 shares0Common StockSEC:0001193125-26-088251:0

▼

Schultes Birgit C

EVP, Chief Scientific OfficerExecutives5 Jan 2026Intellia Therapeutics, Inc.

$78,35937SEC ↗

8,508 shares@ US$9.2199.3% of flowCommon StockSEC:0001193125-26-006292:0

▼

Schultes Birgit C

EVP, Chief Scientific OfficerExecutives1 Oct 2025Intellia Therapeutics, Inc.

$53931SEC ↗

31 shares@ US$17.38100.0% of flowCommon StockSEC:0001193125-25-230424:0

◆

Schultes Birgit C

EVP, Chief Scientific OfficerExecutives1 Mar 2025Intellia Therapeutics, Inc.

0SEC ↗

37,600 shares0Common StockSEC:0000950170-25-032101:0

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

SB

Schultes Birgit C

OFFICER

·SEC (Form 4)

Intellia Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€67,406

▼ Sales (2 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

2

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the detailed record of transactions filed by Schultes Birgit C. Insider active across 1 company, notably Intellia Therapeutics, Inc.. In total, 4 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €67k. History available since 1 March 2025. The latest transaction was filed on 1 March 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.